StockData
Apnimed, Inc. logo

Apnimed, Inc. (APMD) shareholders

APMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Nov 13, 2026
$16.92+0.29 (+1.74%)

Close on Nov 13, 2026Market cap $81.25MP/E –Yield –

Ownership

Who owns Apnimed's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
2 buys · 0 sales
Net bought $5.20M

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Ameriprise Financial, Inc.
Joint filing with Columbia Management Investment Advisers, LLC (18.90%), Columbia Seligman Technology and Information Fund (18.20%)
7,476,99218.90%13G (passive)Jul 31, 2026
Shionogi & Co Ltd2,953,8177.10%13G (passive)Sep 30, 2026
Tao Capital Management LP2,178,1385.20%13G (passive)Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Kevin Robert LindChief Executive Officer, Director––Aug 3, 2026
Michael B. KellyChief Financial Officer––Aug 3, 2026
Dennis Patrick MolnarPresident58,0140.14%Aug 3, 2026
Paul R. FonteyneDirector––Aug 3, 2026
William A. Jones JrDirector––Aug 3, 2026
Paul J. SekhriDirector12,5000.03%Aug 3, 2026
Gary SenderDirector––Aug 3, 2026
Lawrence G. MillerDirector459,0921.10%Aug 3, 2026
Chris DimitropoulosDirector––Jul 30, 2026
Holding RSC Ltd Lunate10% owner5,542,47613.31%Aug 5, 2026
Venture Investments Ltd Morningside10% owner7,303,96117.54%Aug 5, 2026
Alpha Wave Global, LP10% owner––Aug 5, 2026
Investment LLC Chimera10% owner––Aug 5, 2026
Alpha Wave Ventures GP, Ltd10% owner––Aug 5, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Holding RSC Ltd Lunate
10% owner
Aug 3, 2026Conversion+4,006,611––5,542,476
Holding RSC Ltd Lunate
10% owner
Aug 3, 2026Conversion+1,001,651––1,001,651
Holding RSC Ltd Lunate
10% owner
Aug 3, 2026Conversion+534,214––1,535,865
Holding RSC Ltd Lunate
10% owner
Aug 3, 2026Conversion+1,512,480$13.50$20.42M7,054,956
Venture Investments Ltd Morningside
10% owner
Aug 3, 2026Conversion+75,624$14.40$1.09M75,624
Venture Investments Ltd Morningside
10% owner
Aug 3, 2026Other−75,624––0
Venture Investments Ltd Morningside
10% owner
Aug 3, 2026Other+75,624––75,624
Venture Investments Ltd Morningside
10% owner
Aug 3, 2026Buy+312,500$16.00$5.00M7,152,713
Venture Investments Ltd Morningside
10% owner
Aug 3, 2026Other−6,840,213––0
Venture Investments Ltd Morningside
10% owner
Aug 3, 2026Conversion+6,840,213––6,840,213
Venture Investments Ltd Morningside
10% owner
Aug 3, 2026Other+6,840,213––6,840,213
Paul J. Sekhri
Director
Aug 3, 2026Buy+12,500$16.00$200.00K12,500
Lawrence G. Miller
Director
Aug 3, 2026Award+88,954––88,954
Lawrence G. Miller
Director
Aug 3, 2026Returned to company−88,954––0
Lawrence G. Miller
Director
Aug 3, 2026Award+88,954––88,954
Lawrence G. Miller
Director
Aug 3, 2026Returned to company−88,954––0
Lawrence G. Miller
Director
Aug 3, 2026Award+88,954––88,954
Lawrence G. Miller
Director
Aug 3, 2026Returned to company−88,954––0
Lawrence G. Miller
Director
Aug 3, 2026Conversion+10,845––103,276
Lawrence G. Miller
Director
Aug 3, 2026Award+92,431––92,431
Lawrence G. Miller
Director
Aug 3, 2026Award+88,954––88,954
Lawrence G. Miller
Director
Aug 3, 2026Returned to company−88,954––0
Lawrence G. Miller
Director
Aug 3, 2026Returned to company−92,431––0
Dennis Patrick Molnar
President
Aug 3, 2026Returned to company−58,014––0
Dennis Patrick Molnar
President
Aug 3, 2026Award+58,014––58,014

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
33.05%
2M shares short
Days to cover
4.5
At 0M shares a day
Change since last report
-12.0%
From 2M shares
Short volume, 20 days
56.0%
Of volume reported to FINRA

Shares sold short, last 3 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Apnimed's stock actually held short. Settlement fails (shares not delivered on time) peaked at 50,733 shares on Sep 21, 2026 over the last 90 days.

See a number that looks wrong?